Surgical therapy for intermediate risk prostate cancer

Optimal surgical management of intermediate risk prostate cancer has yet to be defined. This is in part due to the heterogeneity of the disease burden in this patient population. When choosing the surgical approach for intermediate risk prostate cancer, urologists should attempt to maximize oncologic outcomes while balancing quality of life concerns. Due to significant risk of failure following solo treatment, multi-modality therapy should be available for those patients with poor pathologic outcomes following surgical therapy.